| Dr Pranav Patel, MD | |
|
1324 Lakeland Hills Blvd, Lakeland, FL 33805-4543 | |
| (863) 284-5050 | |
| (863) 284-6720 |
| Full Name | Dr Pranav Patel |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 24 Years |
| Location | 1324 Lakeland Hills Blvd, Lakeland, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184812216 | NPI | - | NPPES |
| 003733200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME109728 (Florida) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | ME109728 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeland Regional Medical Center | Lakeland, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakeland Regional Health Systems Inc | 8325952914 | 346 |
News Archive
A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.
Senate Finance Committee Chairman Max Baucus, D-Mont., says that a comprehensive health reform package - due out from his committee within the next week or two - will include plans to compare the effectiveness of drugs and other medical treatments so Americans can answer the question: "What are we getting for our money?"
ADVANCELL, an emerging Spanish biopharmaceutical company, has initiated a phase IIb clinical study of the Company's ATH008, for the treatment of the palmar-plantar erythrodysesthesia syndrome, also known as hand-foot syndrome, a painful side-effect of certain chemotherapies such as capecitabine and fluoropyrimidines.
› Verified 3 days ago
| Entity Name | Lakeland Regional Health Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497748743 PECOS PAC ID: 8325952914 Enrollment ID: O20031118000384 |
News Archive
A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.
Senate Finance Committee Chairman Max Baucus, D-Mont., says that a comprehensive health reform package - due out from his committee within the next week or two - will include plans to compare the effectiveness of drugs and other medical treatments so Americans can answer the question: "What are we getting for our money?"
ADVANCELL, an emerging Spanish biopharmaceutical company, has initiated a phase IIb clinical study of the Company's ATH008, for the treatment of the palmar-plantar erythrodysesthesia syndrome, also known as hand-foot syndrome, a painful side-effect of certain chemotherapies such as capecitabine and fluoropyrimidines.
› Verified 3 days ago
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.
Senate Finance Committee Chairman Max Baucus, D-Mont., says that a comprehensive health reform package - due out from his committee within the next week or two - will include plans to compare the effectiveness of drugs and other medical treatments so Americans can answer the question: "What are we getting for our money?"
ADVANCELL, an emerging Spanish biopharmaceutical company, has initiated a phase IIb clinical study of the Company's ATH008, for the treatment of the palmar-plantar erythrodysesthesia syndrome, also known as hand-foot syndrome, a painful side-effect of certain chemotherapies such as capecitabine and fluoropyrimidines.
› Verified 3 days ago
| Entity Name | Intensive Care Consortium Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629019062 PECOS PAC ID: 0244269413 Enrollment ID: O20050808000883 |
News Archive
A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.
Senate Finance Committee Chairman Max Baucus, D-Mont., says that a comprehensive health reform package - due out from his committee within the next week or two - will include plans to compare the effectiveness of drugs and other medical treatments so Americans can answer the question: "What are we getting for our money?"
ADVANCELL, an emerging Spanish biopharmaceutical company, has initiated a phase IIb clinical study of the Company's ATH008, for the treatment of the palmar-plantar erythrodysesthesia syndrome, also known as hand-foot syndrome, a painful side-effect of certain chemotherapies such as capecitabine and fluoropyrimidines.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pranav Patel, MD 1222 S Orange Ave, Orlando, FL 32806-1215 Ph: (321) 841-7856 | Dr Pranav Patel, MD 1324 Lakeland Hills Blvd, Lakeland, FL 33805-4543 Ph: (863) 284-5050 |
News Archive
A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.
Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced results from its recently completed Phase 1 clinical trial evaluating the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of subcutaneous bolus and subcutaneous infusion of cenderitide in patients with chronic heart failure.
Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.
Senate Finance Committee Chairman Max Baucus, D-Mont., says that a comprehensive health reform package - due out from his committee within the next week or two - will include plans to compare the effectiveness of drugs and other medical treatments so Americans can answer the question: "What are we getting for our money?"
ADVANCELL, an emerging Spanish biopharmaceutical company, has initiated a phase IIb clinical study of the Company's ATH008, for the treatment of the palmar-plantar erythrodysesthesia syndrome, also known as hand-foot syndrome, a painful side-effect of certain chemotherapies such as capecitabine and fluoropyrimidines.
› Verified 3 days ago
Dr. Elijah Kim, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-687-1321 Fax: 863-284-1786 | |
Dr. Julia Mcneice, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 | |
Christian Abreu-ramirez, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-687-1100 | |
Robert H Bevis, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 | |
Dr. Lilliam S. Chiques-colon, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Dr. Lijian Wang, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Eric Lipson, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 |